Enhance the anti-renca carcinoma effect of a DNA vaccine targeting G250 gene by co-expression with cytotoxic T-lymphocyte associated antigen-4(CTLA-4)-Reference-Cited by-同舟云学术

Enhance the anti-renca carcinoma effect of a DNA vaccine targeting G250 gene by co-expression with cytotoxic T-lymphocyte associated antigen-4(CTLA-4)

Published:2017-06 Issue: Volume:90 Page:147-152
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhao Youguang,Wei Zhitao,Yang Hang,Li Xiaowei,Wang Qiwu,Wang Liang,Li Shadan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference18 articles.

1. Recent advances in immunotherapy for kidney cancer;Ball;Discov. Med.,2016

2. Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway;Zhang;Oncol. Targets Ther.,2016

3. Expression of epithelial–mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy;Harada;BJU Int.,2012

4. An enhanced immune response against G250, induced by a heterologous DNA prime-protein boost vaccination, using polyethyleneimine as a DNA vaccine adjuvant;Sun;Mol. Med. Rep.,2014

5. Poly(ethylene glycol)-grafted polyethylenimine modified with G250 monoclonal antibody for tumor gene therapy;Duan;Hum. Gene Ther.,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of a novel multiepitope vaccine with CTLA-4 extracellular domain against Mycoplasma pneumoniae: A vaccine-immunoinformatics approach;Vaccine;2024-07

2. The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma;npj Vaccines;2023-08-04

3. The future of cancer immunotherapy: DNA vaccines leading the way;Medical Oncology;2023-06-09

4. CAD v1.0: Cancer Antigens Database Platform for Cancer Antigen Algorithm Development and Information Exploration;Frontiers in Bioengineering and Biotechnology;2022-05-12

5. Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity;Molecular Therapy - Oncolytics;2022-03